Global  

Celebrating 10 Years of Trusted News Discovery
One News Page
> > >

FDA finds small amounts of probable carcinogen in Zantac and other heartburn drugs

USATODAY.com Friday, 13 September 2019
The FDA tested ranitidine heartburn medications and found small amounts of a probable carcinogen. The agency has not recommended the drugs be recalled
0
shares
ShareTweetSavePostSend
 
Credit: Rumble - Published < > Embed
News video: FDA Finds Traces Of Probable Carcinogen In Some Heartburn Drugs

FDA Finds Traces Of Probable Carcinogen In Some Heartburn Drugs 00:58

​The FDA says Zantac-brand heartburn medicines contain small amounts of a known &quot;probable carcinogen.&quot;

You Might Like


Recent related videos from verified sources

FDA: No Carcinogens In OTC Heartburn Meds [Video]FDA: No Carcinogens In OTC Heartburn Meds

Zantac and its generic versions, known chemically as ranitidine, are popular heartburn medicines. Reuters reports they have not been found to contain the carcinogen that ranitidine has been linked..

Credit: Wochit     Duration: 00:46Published

Pharmacy Chains Pull Heartburn Drug Zantac From Shelves [Video]Pharmacy Chains Pull Heartburn Drug Zantac From Shelves

In September, the Food and Drug Administration warned that a heartburn drug may contain a cancer-causing chemical. Over the weekend, the chain pharmacy CVS announced it would stop selling all versions..

Credit: Wochit     Duration: 00:36Published

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2019 One News Page Ltd. All Rights Reserved.
About us  |  Contact us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  In the News  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? FeedbackSend us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter  •  FOLLOW us on Pinterest
One News® is a registered trademark of One News Page Ltd.